Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API      

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 


      © 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved

Irinotecan-Hcl Taj Pharma API

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  

Irinotecan Hcl Manufacturers in India Suppliers Irinotecan Hcl Dossage Exporters Distributors Irinotecan Hcl api active pharmaceuticals ingredients Irinotecan Hcl manufacturers Side Effects bulk drugs raw material Dossage Irinotecan Hcl companies Side Effects Dossage Importers Irinotecan Hcl Dossage Irinotecan Hcl Exporters Irinotecan Hcl exporters Dossage FDA Dossage Irinotecan Hcl Dossage DMF Symptoms Dossage Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Irinotecan Hydrochloride manufacturing pharmaceutical drugs pharmaceutical intermediates Irinotecan Hydrochloride pharmaceutical chemicals pharmaceutical raw materials Irinotecan Hydrochloride active pharmaceutical ingredients Irinotecan Hydrochloride committee active pharmaceutical ingredients manufacturer Irinotecan Hydrochloride Active Pharmaceutical Ingredients manufacturer Irinotecan Hydrochloride exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Irinotecan Hcl, Irinotecan Hcl manufacturer India, Irinotecan Hcl product, Irinotecan Hcl products, Api preparation, Certificate of Analysis API manufacturer product, Irinotecan Hcl anti ulcer product, Certificate of Origin COA Irinotecan Hcl COS Irinotecan Hcl, pharmaceutical generic, pharmaceutical drug, medical, Irinotecan Hcl pharma healthcare, pharma patents, contract MSDS manufacturing Trader Irinotecan Hcl pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Irinotecan Hcl expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Irinotecan Hcl DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Irinotecan Hcl ingredients, api, HIV Irinotecan Hcl, tablets, capsules, syrup & protein Irinotecan Hcl powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Irinotecan Hcl gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Irinotecan Hcl WHO, UKMHRA Approval

   PRODUCT LIST
   Home
   API >>>
   Pharmaceuticals API List
   Chemicals
   Manufacturing
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
 

Irinotecan-Hcl img.




















 







 

 

HOME >> API >> API List 2 >> Irinotecan Hcl >> Dosage

Molecular Formula C33H38N4O6.HCl


DOSAGE
Irinotecan Hcl CAS Registry Number 100286-90-6



Irinotecan may be given:

* as a drip (infusion) through a fine tube (cannula) inserted into a vein
* through a central line, which is inserted under the skin into a vein near the collarbone, or into a PICC line, which is inserted into a vein in the crook of your arm.

Chemotherapy is usually given as a course of several sessions (or cycles) of treatment over a few months. The length of your treatment and the number of cycles you have will depend on the type of cancer for which you are being treated. Irinotecan is commonly given alongside other chemotherapy drugs as part of a combination regimen. Your nurse or doctor will discuss your treatment plan with you.
Irinotecan is given as an injection through a needle placed into a vein. You will receive this injection in a clinic or hospital setting. The medicine must be given slowly through an IV infusion, and can take up to 90 minutes to complete. The irinotecan injection is usually followed by infusions with other cancer medications. These combination chemotherapy treatments are usually given at weekly intervals for several weeks.

Before starting your irinotecan injection, you may be given medications to help prevent nausea, vomiting, diarrhea, and other side effects. You may also need to use some of these medications for at least a day after your irinotecan injection.
Irinotecan can cause severe diarrhea, which can be life-threatening if it leads to dehydration. Diarrhea can occur soon after your injection or more than 24 hours later.

Your doctor may recommend you have an anti-diarrhea medicine such as loperamide (Imodium) available at all times while you are receiving irinotecan. The anti-diarrhea medication is usually taken at the first sign of loose or frequent bowel movements.

Information Associated with Product:
DRUG DESCRIPTION
DOSAGE >>
SIDE EFFECTS
PRECAUTIONS
INTERACTION
CONSUMER INFORMATION
 
 
PDF DOWNLOAD WORD DOCUMENT
Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  

Taj Pharmaceuticals API Logo

Irinotecan Hcl

Api Manufacturer,Export,Supplies,Manufacturing

Gabapentin

Gemcitabine Hcl

Glimepiride

Granisetron Hcl

Ibandronate Sodium

Imatinib Mesylate

Irbesartan

Irinotecan Hcl

Isradipine

Lamotrigine

Lercanidipine

Letrozole

Losartan Potassium

Loteprednol Etabonate

Magnesium Valproate

Meloxicam

Memantine Hcl

Mesalazine

Metamizol Magnesium

Metaxalone

Metformin Hcl

Metoprolol Tartrate

Mifepristone

Mirtazapine

Modafinil

Mometasone Furoate

Naltrexone Hcl

Netaglinide

Copyright © Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

Investor Relations    Feedback     Contact Worldwide    Sitemap
 

taj group logo
© 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.